New single-source drug submissions under review

Information on the status of manufacturers' drug submissions that allows industry stakeholders and the public to track the status of drug submissions through the various stages of the review cycle.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 20:16 (TU)
Créé le avril 17, 2026, 20:16 (TU)
contact_person {"en": "Health", "fr": "Health"}
criticality_level []
data_dictionary ["economy"]
geographic_scope []
open_canada_collection federated
open_canada_date_published 2023-10-20 00:00:00
open_canada_keywords {"en": ["Données Ontario", "drug submission status", "status of single-source submissions", "single-source drug submissions under review", "brand name drugs"], "fr-t-en": ["Ontario data", "état de la présentation des médicaments", "statut des soumissions provenant d'une source unique", "les présentations de médicaments provenant de sources uniques sont en cours d'examen", "médicaments de marque"]}
open_canada_subject ["government_and_politics"]
sensitivity_level unrestricted
title_fr Nouvelles présentations de médicaments à source unique en cours d’examen
update_frequency P1M